ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
127.140,11
-0,82%
S&P 500
5.917,11
0,00%
US Dollar vs BRL
5,8203
0,83%
Bitcoin
97.681,35
3,53%
Brent Oil
73,845
1,38%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Notícias

AZN

Astrazeneca (AZN)

Astrazeneca Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:AZN
DataHoraFonteTítuloCódigoCompanhia
20/11/202413:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
19/11/202412:47Alliance NewsAlliance NewsAstraZeneca "disappointed" as breast cancer drug blocked for NHS useLSE:AZNAstrazeneca Plc
18/11/202409:43Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buyLSE:AZNAstrazeneca Plc
18/11/202406:01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoLSE:AZNAstrazeneca Plc
18/11/202404:00RNS Regulatory NewsAstraZeneca PLC Tagrisso recommended for EU approval - LAURALSE:AZNAstrazeneca Plc
15/11/202408:04Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in sharesLSE:AZNAstrazeneca Plc
12/11/202416:50Alliance NewsAlliance NewsIN BRIEF: Merck trial shows Koselugo effective in treating adultsLSE:AZNAstrazeneca Plc
12/11/202409:21Alliance NewsAlliance NewsEXTRA: AstraZeneca results impress but China a likely short-term dragLSE:AZNAstrazeneca Plc
12/11/202405:59Alliance NewsAlliance NewsTOP NEWS: AstraZeneca lifts annual guidance despite possible forex hitLSE:AZNAstrazeneca Plc
12/11/202404:10RNS Regulatory NewsAstraZeneca PLC AstraZeneca invests $3.5 billion in USLSE:AZNAstrazeneca Plc
12/11/202404:05RNS Regulatory NewsAstraZeneca PLC KOMET Phase III trial met primary endpointLSE:AZNAstrazeneca Plc
12/11/202404:00RNS Regulatory NewsAstraZeneca PLC 9M and Q3 2024 ResultsLSE:AZNAstrazeneca Plc
12/11/202404:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd new BLA submitted, NSQ BLA withdrawnLSE:AZNAstrazeneca Plc
08/11/202406:13Alliance NewsAlliance NewsAstraZeneca touts positive results from nasal polyp treatment studyLSE:AZNAstrazeneca Plc
08/11/202404:00RNS Regulatory NewsAstraZeneca PLC Tezspire nasal polyps trial met primary endpointsLSE:AZNAstrazeneca Plc
07/11/202408:14Alliance NewsAlliance NewsTOP NEWS: AstraZeneca says China chief detained as under investigationLSE:AZNAstrazeneca Plc
05/11/202415:39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca pledges to assist in China probe as shares slideLSE:AZNAstrazeneca Plc
05/11/202413:49RNS Regulatory NewsAstraZeneca PLC AZN share price movementLSE:AZNAstrazeneca Plc
01/11/202412:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
30/10/202411:30Alliance NewsAlliance NewsIN BRIEF: AstraZeneca China President Leon Wang under investigationLSE:AZNAstrazeneca Plc
28/10/202405:46Alliance NewsAlliance NewsAstraZeneca pleased as EU approves Fasenra for treatment of EGPALSE:AZNAstrazeneca Plc
21/10/202404:35Alliance NewsAlliance NewsAstraZeneca polyneuropathy treatment recommended for EU approvalLSE:AZNAstrazeneca Plc
21/10/202403:00RNS Regulatory NewsAstraZeneca PLC Wainzua recommended for approval in the EULSE:AZNAstrazeneca Plc
16/10/202405:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:AZNAstrazeneca Plc
14/10/202406:42Alliance NewsAlliance NewsTOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in ChinaLSE:AZNAstrazeneca Plc
07/10/202406:20Alliance NewsAlliance NewsAstraZeneca enters agreement to strengthen cardiovascular pipelineLSE:AZNAstrazeneca Plc
07/10/202405:30RNS Regulatory NewsAstraZeneca PLC AstraZeneca licenses lipid lowering Lp(a) assetLSE:AZNAstrazeneca Plc
07/10/202404:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails Airsupra trial results to treat asthmaLSE:AZNAstrazeneca Plc
03/10/202407:01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Calquence gets priority review in USLSE:AZNAstrazeneca Plc
01/10/202405:39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in USLSE:AZNAstrazeneca Plc
 Apresentando as notícias mais relevantes sobre:LSE:AZN

Seu Histórico Recente

TSX
TVK
TerraVest Industries
DOWI
DJCIRBT
DJ Commodity Index Unlea...
DOWI
DJCSO1IT
DJ Commodity Index Soybe...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados